Pratt P C, Vollmer R T
Chest. 1984 Mar;85(3):372-7. doi: 10.1378/chest.85.3.372.
A collection of 204 inflation-fixed autopsy lungs was divided into three groups: normal, 93; centrilobular emphysema (CLE), 88; and "other," 23; the last includes lungs with other chronic processes. Clinical hospital records were reviewed to ascertain smoking history (no smoking, 31; smoking, 173) and alcohol use (none, 73; slight-to-moderate (Sli-Mod) drinkers, 66; heavy drinkers, 65). Lungs were subjected to morphometric determination of the extent of CLE, mucous gland hyperplasia in large airways, and goblet cell metaplasia in bronchioles. Prevalence of CLE diminished progressively as alcohol use increased. A logistic analysis showed that alcohol use was significantly associated (p less than 0.008) with reduced extent of CLE even after allowing for age and smoking effects. This apparent prophylactic effect of alcohol against CLE probably results from inhibition of inflammatory cells. It suggests that a drug with similar effects but without the deleterious side effects of alcohol might provide a meaningful degree of protection against emphysema in smokers.
收集了204个经固定防止膨胀的尸检肺脏,并将其分为三组:正常组,93个;小叶中心型肺气肿(CLE)组,88个;以及“其他”组,23个;最后一组包括患有其他慢性病变的肺脏。查阅了临床医院记录以确定吸烟史(不吸烟,31例;吸烟,173例)和饮酒情况(不饮酒,73例;轻度至中度饮酒者,66例;重度饮酒者,65例)。对肺脏进行了形态计量学测定,以确定CLE的范围、大气道中的黏液腺增生以及细支气管中的杯状细胞化生情况。随着饮酒量的增加,CLE的患病率逐渐降低。逻辑分析表明,即使考虑到年龄和吸烟的影响,饮酒与CLE范围的缩小仍显著相关(p小于0.008)。酒精对CLE的这种明显的预防作用可能是由于对炎症细胞的抑制。这表明,一种具有类似作用但没有酒精有害副作用的药物可能为吸烟者提供有意义的肺气肿防护。